About Neuheit Pharma Private Limited
Data last updated:
Neuheit Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Neuheit Pharma Technologies Private Limited. The company has been dissolved under section 59(8) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2015.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2015PTC098047. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹24.1 Cr and a paid-up capital of ₹23.1 Cr. It was led by directors including Srinivas Irukulla (Managing Director) and Patrick Mark Dentinger.
Its last annual general meeting (AGM) was held on 02 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹10.74 Cr and EBITDA of -₹5.65 Cr. Revenue has grown at a compounded annual rate (CAGR) of 121% over three years.
The company had about 36 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹12.5 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 3 deals on record (3 funding rounds), with disclosed funding of ₹20.05 Cr; the latest was in September 2018. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Biocare Remedies Pvt Ltd with revenue of ₹1.1 Cr.
The last known website on record is neuheitpharma.com.
Company details
Contact details
Neuheit Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is neuheitpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlotno 43&44 Aleapindustrial Estate Gajularamaram Nearpragthinagar Opp:Jntu Universtiy Kuk, Atpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neuheit Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neuheit Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Neuheit Pharma Private Limited, buy the company report.
Financials of Neuheit Pharma Private Limited
FY 2020 filings availableNeuheit Pharma Private Limited reported revenue of ₹1.1 Cr (up 935% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 121% over three years, including 935% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.1 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neuheit Pharma Private Limited, buy the company report.
Board of directors of Neuheit Pharma Private Limited
Neuheit Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Patrick Mark Dentinger | Director | 10 Aug 2017 | 9 Years 2 Months | As last reported |
| Siddhartha Bhoopathy | Director | 10 Aug 2017 | 9 Years 2 Months | As last reported |
| Venkateswarlu Vobalaboina Also directs: Neuheit Pharma Technologies Private Limited | Director | 16 Mar 2015 | 11 Years 7 Months | As last reported |
| Srinivas Irukulla | Managing Director | 16 Mar 2015 | 11 Years 7 Months | As last reported |
Peer comparison
Neuheit Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocare Remedies Pvt Ltd | ₹1.1 Cr (FY 2024) | Gandhinagar, Gujarat, India | ||||
| Khevo Pharmaceuticals Private Limited | ₹1.1 Cr (FY 2025) | 45.0% | Pune, Maharashtra, India | |||
| Neuheit Pharma Private Limitedthis company | ₹1.1 Cr (FY 2020) | -₹10.74 Cr | 935.0% | Hyderabad, Telangana, India | ||
| Svi Healthcare Private Limited | ₹1.1 Cr (FY 2022) | -30.0% | Panipat, Haryana, India |
To see the full peer comparison of Neuheit Pharma Private Limited, buy the company report.
Auditor
Neuheit Pharma Private Limited is audited by NANDYALA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NANDYALA & ASSOCIATES | FY 2020 | 005646S |
Shareholding
The shareholding of Neuheit Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neuheit Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Nov 2018 | 100223621 | Others | ₹12.5 Cr | Satisfied |
To see the full charge records of Neuheit Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Neuheit Pharma Private Limited has 3 deals on record (3 funding rounds), with disclosed funding of ₹20.05 Cr; the latest was in September 2018.
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Funding round | ₹2.5 Cr | Investors: Clayton Pharmaceuticals LLC |
| Jun 2018 | Funding round | ₹2.55 Cr | Investors: Clayton Pharmaceuticals LLC |
To see the full deal history of Neuheit Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Neuheit Pharma Private Limited has 1 court case on record: 1 filed by Neuheit Pharma. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Insolvency matter | Filed by the company | Disposed |
To see the full case history of Neuheit Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neuheit Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neuheit Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Neuheit Pharma Private Limited, buy the company report.
Recent activity
Neuheit Pharma Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Patrick Mark Dentinger was appointed as Director on 10 Aug 2017.
Frequently asked questions
Neuheit Pharma has been "Dissolved Under Section 59(8)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Neuheit Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2015 and is registered under CIN U24233TG2015PTC098047. The company is recorded as dissolved under section 59(8) in MCA records and no longer exists as a legal entity.
Neuheit Pharma was incorporated on 16 March 2015. It is registered with the Registrar of Companies, Hyderabad.
Neuheit Pharma had 4 directors:
- Srinivas Irukulla - Managing Director
- Patrick Mark Dentinger - Director
- Siddhartha Bhoopathy - Director
- Venkateswarlu Vobalaboina - Director
The CIN (Corporate Identification Number) of Neuheit Pharma is U24233TG2015PTC098047. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Neuheit Pharma is at Plotno 43&44 Aleapindustrial Estate Gajularamaram Nearpragthinagar Opp:Jntu Universtiy Kuk, Atpally, Hyderabad, Telangana, India – 500072.
Neuheit Pharma can be reached through the website neuheitpharma.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Neuheit Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 02 December 2020. Year-wise statements from 2015 are in the company report.
No. Neuheit Pharma has 1 GST registration on record and it is cancelled or inactive.
Neuheit Pharma operated in the pharma industry, in the drug formulation and development segment.
Neuheit Pharma has 3 deals on record (3 funding rounds), with disclosed funding of ₹20.05 Cr; the latest was in September 2018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
